Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa B Schrock

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
JCO Precision Oncology|June 15, 2022
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular LandscapeIbiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, et al.
Cancer|January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.
JCO Precision Oncology|April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignanciesPrimo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.
Lung Cancer (Auckland, N.Z.)|May 6, 2020
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the <i>ALK</i> Gene Have Durable Responses to ALK Kinase InhibitorsAlexa B Schrock, Russell Madison, Mark Rosenzweig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|June 15, 2022
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular LandscapeIbiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, et al.
Cancer|January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibitionDavid A Fabrizio, Thomas J George, Richard F Dunne, et al.
JCO Precision Oncology|April 10, 2018
TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignanciesPrimo N Lara, Andreas M Heilmann, Julia A Elvin, et al.
Breast Cancer Research and Treatment|February 18, 2017
Comprehensive genomic profiling of malignant phyllodes tumors of the breastSahar Nozad, Christine E Sheehan, Laurie M Gay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.
Lung Cancer (Auckland, N.Z.)|May 6, 2020
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the <i>ALK</i> Gene Have Durable Responses to ALK Kinase InhibitorsAlexa B Schrock, Russell Madison, Mark Rosenzweig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2016
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping AlterationsAlexa B Schrock, Garrett M Frampton, James Suh, et al.
Pageof 13